Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Pain and neurocognitive disorders: current state of the art and remaining challenges].
Achterberg WP, de Waal MWM, Cheuk-A-Lam-Balrak JMJJ, Crutzen-Braaksma P, van Dalen-Kok A, van Dam P, de Knegt NC, van Kooten J, Lobbezoo F, Smaling HJA, Sprenger GP, van der Steen JT, de Vries CNJ, Zwakhalen SMG, Smalbrugge M, Oosterman JM. Achterberg WP, et al. Among authors: van dam p, van der steen jt, van kooten j, van dalen kok a. Tijdschr Gerontol Geriatr. 2022 Nov 24;53(4). doi: 10.36613/tgg.1875-6832/2022.04.04. eCollection 2022 Nov 24. Tijdschr Gerontol Geriatr. 2022. PMID: 37013709 Review. Dutch.
An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study).
Trozzi R, Tuyaerts S, Annibali D, Herreros Pomares A, Boog L, Van Dam P, Leunen K, Deroose C, Trum H, Amant F. Trozzi R, et al. Among authors: van dam p. Int J Gynecol Cancer. 2024 May 9:ijgc-2023-005229. doi: 10.1136/ijgc-2023-005229. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38724237
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant.
Van Berckelaer C, Van Laere S, Lee S, Morse MA, Geradts J, Dirix L, Kockx M, Bertucci F, Van Dam P, Devi GR. Van Berckelaer C, et al. Among authors: van dam p. Transl Oncol. 2024 May;43:101907. doi: 10.1016/j.tranon.2024.101907. Epub 2024 Feb 27. Transl Oncol. 2024. PMID: 38412664 Free PMC article.
404 results